Fundamentals

Valuation

Metric	Q1	Q2	Δ in %
EV/EBITDA	-30.77	44.67	64.52
Graham Fair Price	13.29	48.13	42.48
PEG	-93.29	0.02	-0.27
Price/Book	7.60	2.91	2.71
Price/Cash Flow	-69.82	-60.67	201.04
Prices/Earnings	-11.95	21.26	24.15
Price/Sales	1.77	5.49	5.39
Price/FCF	-69.82	-60.67	201.04
Naive Interpretation	member

01 - Valuation · Somewhat Weak

Fundamentals

Profitability

Metric	Q1	Q2	Δ in %
Gross Profit Margin	5.37	0.29	0.27
Operating Margin	21.03	0.12	0.10
ROA	23.91	0.01	0.01
ROE	0.03	0.03	22.20
ROIC	0.02	0.02	27.42
Naive Interpretation	member

02 - Profitability · Not Interpreted

Fundamentals

Financial Growth

Metric	Q1	Q2	Δ in %
Debt QOQ	0.03	0.07	-53.09
Dividends QOQ	< 0.005	0.04	327.47
EBIT QOQ	< 0.005	0.31	4513.84
EPS QOQ	-0.88	11.53	1212.05
FCF QOQ	-0.78	-4.66	-496.97
Revenue QOQ	-0.02	0.09	391.78
Naive Interpretation	member

03 - Financial Growth · Positive

Fundamentals

Leverage & Liquidity

Metric	Q1	Q2	Δ in %
Assets Turnover	n.A.	n.A.	n.A.
Days Inventory Outstanding (DIO)	113.72	109.93	-3.33
Days Sales Outstanding (DSO)	119.97	117.40	-2.14
Inventory Turnover	0.79	0.82	3.45
Debt/Capitalization	0.52	0.52	0.19
Quick Ratio	1.26	1.27	0.85
Naive Interpretation	member

04 - Leverage & Liquidity · Weak

Fundamentals

Per Share Metrics

Metric	Q1	Q2	Δ in %
Book Value	53.51	54.84	2.49
Cash	3.96	1.85	-53.37
Capex	-1.17	-1.25	-6.99
Free Cash Flow	0.72	-2.63	265.37
Revenue	26.86	29.10	8.35
Naive Interpretation	member

05 - Per Share Metrics · Positive

Fundamentals

Financial Health

Metric	Q1	Q2	Δ in %
Current Ratio	2.10	2.15	2.44
Debt/Assets	n.A.	n.A.	n.A.
Debt/Equity	n.A.	n.A.	n.A.
Net Debt/EBITDA	9.46	6.63	-29.92
Naive Interpretation	Member

06 - Financial Health · Bad

Rating